Stoke Therapeutics, Inc. Operating Margin in % from 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Stoke Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2022 to Q3 2025.
  • Stoke Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2025 was 13.2 %.
  • Stoke Therapeutics, Inc. annual Operating Margin for 2024 was -277 %, a 78.8% increase from 2023.
  • Stoke Therapeutics, Inc. annual Operating Margin for 2023 was -1.31K %, a 55.4% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Stoke Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 13.2 +714 Jul 1, 2025 Sep 30, 2025
Q2 2025 20.2 +776 Apr 1, 2025 Jun 30, 2025
Q1 2025 20 +1.53K Jan 1, 2025 Mar 31, 2025
Q4 2024 -277 +1.03K +78.8% Oct 1, 2024 Dec 31, 2024
Q3 2024 -701 +514 +42.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -756 +514 +40.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -1.51K -794 -111% Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.31K -466 -55.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.21K Jul 1, 2023 Sep 30, 2023
Q2 2023 -1.27K Apr 1, 2023 Jun 30, 2023
Q1 2023 -716 Jan 1, 2023 Mar 31, 2023
Q4 2022 -841 Oct 1, 2022 Dec 31, 2022

Stoke Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -277 +1.03K +78.8% Jan 1, 2024 Dec 31, 2024
2023 -1.31K -466 -55.4% Jan 1, 2023 Dec 31, 2023
2022 -841 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.